Evidence map›Paper›PMID 33665578›Full record

ArticleiScience2021

Industrially scalable surface treatments to enhance the current density output from graphite bioanodes fueled by real domestic wastewater.

Emma Roubaud, Rémy Lacroix, Serge Da Silva, Jérôme Esvan, Luc Etcheverry, Alain Bergel, Régine Basséguy, Benjamin Erable

Abstract read
In one paragraph

Article in iScience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Emma RoubaudLaboratoire de Génie Chimique, Université de Toulouse, CNRS, INPT, UPS, Toulouse, France.
Rémy Lacroix6T-MIC Ingénieries, 9 rue du développement - ZI de Vic, 31320 Castanet-Tolosan, France.
Serge Da Silva6T-MIC Ingénieries, 9 rue du développement - ZI de Vic, 31320 Castanet-Tolosan, France.
Jérôme EsvanCirimat, Université de Toulouse, CNRS-INP-UPS, 4 allée Emile MONSO, BP 44362, 31030 Toulouse, France.
Luc EtcheverryLaboratoire de Génie Chimique, Université de Toulouse, CNRS, INPT, UPS, Toulouse, France.
Alain BergelLaboratoire de Génie Chimique, Université de Toulouse, CNRS, INPT, UPS, Toulouse, France.
Régine BasséguyLaboratoire de Génie Chimique, Université de Toulouse, CNRS, INPT, UPS, Toulouse, France.
Benjamin ErableLaboratoire de Génie Chimique, Université de Toulouse, CNRS, INPT, UPS, Toulouse, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acid and electrochemical surface treatments of graphite electrode, used individually or in combination, significantly improved the microbial anode current production, by +17% to +56%, in well-regulated and duplicated electroanalytical experimental systems. Of all the consequences induced by surface treatments, the modifications of the surface nano-topography preferentially justify an improvement in the fixation of bacteria, and an increase of the specific surface area and the electrochemically accessible surface of graphite electrodes, which are at the origin of the higher performances of the bioanodes supplied with domestic wastewater. The evolution of the chemical composition and the appearance of C-O, C=O, and O=C-O groups on the graphite surface created by combining acid and electrochemical treatments was prejudicial to the formation of efficient domestic-wastewater-oxidizing bioanodes. The comparative discussion, focused on the positioning of the performances, shows the industrial interest of applying the surface treatment method to the world of bioelectrochemical systems.

Indexed as

ElectrochemistryMicrobiofilmsSurface Science

Identifiers

PMID33665578
PMCPMC7907815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.